Barry Slifstein
Analyst · Gabelli & Company
Thanks Frank and good morning everyone. Thank you for joining us on today's call. During the quarter, the company took a non-cash net charge of $83.5 million related to the possible repatriation of overseas earnings to fund the remaining obligations in the SPHC settlement. I will therefore review the results of operations for our fiscal 2015 third quarter on an as adjusted basis excluding the $83.5 million non-cash charge and then cover some February 28, 2015 balance sheet and cash flow items. I'll then turn the call over to Rusty, who will discuss the outlook for the balance of fiscal 2015. Third quarter consolidated net sales of $946.4 million increased 9.6% from last year. Organic sales increased 6.7%. Acquisition growth added an additional 8.5% and foreign currency translation reduced sales by 5.6%. Industrial segment sales increased 10.6% year-over-year to $620.0 million. Organic growth increased 5.5%. Acquisition growth added an additional 12.4% and foreign currency translation reduced sales by 7.3%. Consumer segment sales increased 7.8% to $326.4 million. Organic growth increased 9.1%. Acquisition growth added an additional 1.2% and foreign currency translation reduced sales by 2.5%. Our consolidated gross profit increased 6.1% by $379.7 million from $358 million last year. As a percent of net sales, gross profit decreased from 41.5% last year to 40.1% this year. Negatively impacting gross profit was foreign currency, unfavorable product mix and $5 million in stepped-up inventory cost at SPHC. Consolidated SG&A increased 7.4% to $346.2 million from $322.2 million last year and as a percent of net sales decreased to 36.6% from 37.3% last year. Nearly all of the increase was due to consolidating the SPHC businesses during the third quarter. Additionally included in SG&A was $3.8 million of non-recurring expenses related to the SPHC settlement. Consolidated earnings before interest and taxes, EBIT, decreased 7.9% to $34.2 million from $37.2 million last year and included the non-recurring SPHC expenses related to the settlement and stepped-up inventory expense. Excluding these two items, consolidated EBIT was $43 million and increased 15.6% over last year. At the industrial segment, EBIT decreased 19.6% to $18.2 million including $5 million in SPHC’s stepped-up inventory expense compared to $22.7 million last year. Consumer segment EBIT increased 13.9% to $35 million compared to $30.8 million last year. Corporate other expenses of $19.1 million were above last year’s amount of $16.3 million primarily due to the $3.8 million non-recurring SPHC settlement expenses mentioned in SG&A. Interest expense increased from $19.7 million last year to $21.5 million this year, primarily due to the $450 million payment to the 524(g) trust in December 2014, which was funded from evolving credit and account receivable securitization facility. Investment income of $7.7 million for the quarter was essentially flat to last year. Income taxes for the third quarter decreased from an effective tax rate of 32.9% last year to an as-adjusted tax benefit this year. The change is primarily due to the reversal of valuation allowances, favorable adjustments to tax contingency reserves and the overall impact of such items relative to the seasonally low actual quarter income. We're forecasting that on an as-adjusted basis, the full year fiscal 2015 effective tax rate will be in line with last year’s full year tax rate. Net income increased 61.2% to $26.2 million from $16.2 million last year. Diluted EPS of $0.20 per share was $0.08 per share or 67.7% above last year's EPS of $0.12 per share. Foreign currency negatively impacted EPS by approximately $0.05 per share and SPHC was dilutive to EPS by $0.01 per share. And now, a quick look at the cash flows and balance sheet. Cash provided by operating activities during the first nine months of the year was $24.1 million versus $25.9 million for the same period last year. Last year’s amount included the GSA payments approximating $45 million after tax. This year’s amount reflects higher working capital needs to fund higher sales, cash payments for professional fees related to the final settlement of SPHC and payments from accrued compensation and benefits and other accrued liabilities. Depreciation and amortization expense was $71.8 million compared to $67.3 million last year. CapEx of $47.3 million this year compared to $54.3 million last year. Our accounts receivable DSO was 73 days this year compared to 70 days last year. Days of inventory increased to 115 days this year compared to 113 days last year. Finally, a few comments on our capital structure and overall liquidity. During the quarter, the company repurchased 550,000 shares in the open market for approximately $26 million. As of February 28, 2015, total debt was $1.87 billion compared to last year at $1.39 billion. The increase was principally due to the $450 million trust payment made in December 2014 using funds from our revolving credit facility. Our net debt-to-capital ratio was 57.2% at February 28, 2015 compared to 47.3% last year. Our long-term liquidity at February 28, 2015, was $648 million with $220 million in cash and $428 million available through our bank revolver and AR securitization facilities. On May 9, 2014, we replaced our existing $150 million accounts receivable securitization facility with a three-year $200 million accounts receivable securitization facility that expires on May 8, 2017. On December 5, 2014, we replaced our existing $600 million revolving credit facility with a new five-year $800 million facility, which can be expanded upon request to $1 billion. The new facility contains customary covenants including a leverage ratio not to exceed 65% and an interest coverage ratio not to be below $3.5 billion to $1 billion. With that, I'll turn the call over to Rusty.